Biosimilarity:The FDA Perspective

生物相似性:美国食品药物管理局观点

食品科学技术基础学科

售   价:
1862.00
发货周期:预计5-7周发货
作      者
出  版 社
出版时间
1800年01月01日
装      帧
精装
ISBN
9781498750394
复制
页      码
456
开      本
7x10
语      种
英文
综合评分
暂无评分
我 要 买
- +
库存 50 本
  • 图书详情
  • 目次
  • 买家须知
  • 书评(0)
  • 权威书评(0)
图书简介
The focus of this book is on how the US FDA will approve biosimilar drugs. The European scene is well developed with specific guidelines that are already in place. However, these guidelines do not apply to the thinking of the FDA in approving these products. The FDA is quite different from other regulatory agencies. With the US providing more than 50% of the worldwide market for these products, every serious manufacturer of biosimilar biological drugs should be targeting US approval of their products. Thus, this book is strictly on FDA approval strategy.
本书暂无推荐
本书暂无推荐
看了又看
  • 上一个
  • 下一个